Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

Cantuti-Castelvetri, Ludovico, Ojha, Ravi, Pedro, Liliana D., Djannatian, Minou, Franz, Jonas, Kuivanen, Suvi, van der Meer, Franziska, Kallio, Katri +21 more·2020·Science
DOI 10.1126/science.abd2985

Cited by (1,003)

Items 701–800 of 1,003

  1. Why are some coronavirus variants more infectious?
    Raju Mukherjee, Rohit Satardekar · 2021 · Journal of Biosciences
  2. Going viral in the islet: mediators of SARS-CoV-2 entry beyond ACE2
    Rohita Rangu, Pandora L Wander, Breanne M Barrow, Sakeneh Zraika · 2022 · Journal of Molecular Endocrinology
  3. Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants
    Daniela Iaconis, Licia Bordi, Giulia Matusali, Carmine Talarico, Candida Manelfi, Maria Candida Cesta, Mara Zippoli, Francesca Caccuri, Antonella Bugatti, Alberto Zani et al. · 2022 · Cell Death and Disease
  4. Mechanistic Understanding of the Olfactory Neuroepithelium Involvement Leading to Short-Term Anosmia in COVID-19 Using the Adverse Outcome Pathway Framework
    Muhammad Ali Shahbaz, F Bernardi, Arto Alatalo, Magdalini Sachana, Laure‐Alix Clerbaux, Amalia Muñoz, Surat Parvatam, Brigitte Landesmann, Katja M. Kanninen, Sandra Coecke · 2022 · Cells
  5. Phenothiazines inhibit SARS-CoV-2 cell entry via a blockade of spike protein binding to neuropilin-1
    Mei Hashizume, Ayako Takashima, Chikako Ono, Toru Okamoto, Masaharu Iwasaki · 2022 · Antiviral Research
  6. In Silico Analysis Reveals the Inhibitory Potential of Madecassic Acid against Entry Factors of SARS-CoV-2
    Abhratanu Ganguly, Moutushi Mandi, Anik Dutta, Prem Rajak · 2023 · ACS Applied Bio Materials
  7. Regulation of angiotensin-converting enzyme 2 isoforms by type 2 inflammation and viral infection in human airway epithelium
    Nino Stocker, Urszula Radzikowska, Paulina Wawrzyniak, Ge Tan, Mengting Huang, Mei Ding, Cezmi A. Akdiş, Milena Sokołowska · 2023 · Mucosal Immunology
  8. Direct and indirect impact of SARS-CoV-2 on the brain
    Jean Pierre Schatzmann Peron · 2023 · Human Genetics
  9. SARS-CoV-2 infects epithelial cells of the blood-cerebrospinal fluid barrier rather than endothelial cells or pericytes of the blood-brain barrier
    Chiara Stüdle, Hideaki Nishihara, Sven Wischnewski, Laila Kulsvehagen, Sylvain Perriot, Hiroshi Ishikawa, Horst Schroten, Stephan Frank, Nikolaus Deigendesch, Renaud Du Pasquier et al. · 2023 · Fluids and Barriers of the CNS
  10. RAGE engagement by SARS-CoV-2 enables monocyte infection and underlies COVID-19 severity
    Roberta Angioni, Matteo Bonfanti, Nicolò Caporale, Ricardo Sánchez‐Rodríguez, Fabio Munari, Aurora Savino, Sebastiano Pasqualato, Damiano Buratto, Isabel Pagani, Nicole Bertoldi et al. · 2023 · Cell Reports Medicine
  11. USP2 inhibition prevents infection with ACE2-dependent coronaviruses in vitro and is protective against SARS-CoV-2 in mice
    Fabin Dang, Lei Bai, Jiazhen Dong, Xiaoping Hu, Jingchao Wang, João A. Paulo, Yan Xiong, Xiaowei Liang, Yishuang Sun, Yuncai Chen et al. · 2023 · Science Translational Medicine
  12. ACE2 interaction with cytoplasmic PDZ protein enhances SARS-CoV-2 invasion
    Qiangmin Zhang, Julia V. Gefter, W. Bruce Sneddon, Tatyana Mamonova, Peter A. Friedman · 2021 · iScience
  13. COVID-19, circadian rhythms and sleep: from virology to chronobiology
    Zulian Liu, Sharlene Ting, Xiaodong Zhuang · 2021 · Interface Focus
  14. Phage-Displayed Mimotopes of SARS-CoV-2 Spike Protein Targeted to Authentic and Alternative Cellular Receptors
    Valery A. Petrenko, James W. Gillespie, Laura Maria De Plano, Michael Shokhen · 2022 · Viruses
  15. SARS-CoV-2 Spike Protein Unlikely to Bind to Integrins via the Arg-Gly-Asp (RGD) Motif of the Receptor Binding Domain: Evidence From Structural Analysis and Microscale Accelerated Molecular Dynamics
    Houcemeddine Othman, Haifa Ben Messaoud, Oussema Khamessi, Hazem Ben Mabrouk, Kaïs Ghedira, Avani Bharuthram, Florette Kathleen Treurnicht, Ikechukwu Achilonu, Yasien Sayed, Najet Srairi‐Abid · 2022 · Frontiers in Molecular Biosciences
  16. Assessment of potential SARS-CoV-2 virus integration into human genome reveals no significant impact on RT-qPCR COVID-19 testing
    Erica M. Briggs, William Steven Ward, Sol Rey, Dylan Law, Katharine Nelson, Michael Bois, Nili Ostrov, Henry H. Lee, Jon M. Laurent, Paolo Mita · 2021 · Proceedings of the National Academy of Sciences
  17. Update in COVID-19 2020
    Sanjay Haresh Chotirmall, Lindsay M. Leither, Başak Çoruh, Louisa Chan, Anthony M. Joudi, Samuel Morris Brown, Benjamin David Singer, Nitin Seam · 2021 · American Journal of Respiratory and Critical Care Medicine
  18. Neuropilin‐1 is required for endothelial cell adhesion to soluble vascular endothelial growth factor receptor 1
    Gianni Colotti, Cristina Maria Failla, Pedro Miguel Lacal, Mariangela Ungarelli, Federica Ruffini, Patrizio Di Micco, Angela Orecchia, Veronica Morea · 2021 · FEBS Journal
  19. Evaluation of sixteen ELISA SARS-CoV-2 serological tests
    Damien Jacot, Milo Moraz, Alix T. Coste, Christèle Aubry, Jilian A. Sacks, Gilbert Greub, Antony Croxatto · 2021 · Journal of Clinical Virology
  20. Instrumental Evaluation of COVID-19 Related Dysautonomia in Non-Critically-Ill Patients: An Observational, Cross-Sectional Study
    Simone Bellavia, Irene Scala, Marco Luigetti, Valerio Brunetti, Maurizio Gabrielli, Lorenzo Zileri Dal Verme, Serenella Servidei, Paolo Calabresi, Giovanni Frisullo, Giacomo Della Marca · 2021 · Journal of Clinical Medicine
  21. Association between COVID-19 Diagnosis and Coronary Artery Thrombosis: A Narrative Review
    Francesco Nappi, Omar Giacinto, Omar Ellouze, Antonio Nenna, Sanjeet Singh Avtaar Singh, Massimo Chello, Assine Bouzguenda, Xavier Copie · 2022 · Biomedicines
  22. Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formation
    Angela Serra, Michele Fratello, Antonio Federico, Ravi Ojha, Riccardo Provenzani, Ervin Tasnádi, Luca Cattelani, Giusy del Giudice, Pia Kinaret, Laura Aliisa Saarimäki et al. · 2021 · Briefings in Bioinformatics
  23. Oral SARS-CoV-2 Inoculation Causes Nasal Viral Infection Leading to Olfactory Bulb Infection: An Experimental Study
    Rumi Ueha, Toshihiro Ito, Ryutaro Furukawa, Masahiro Kitabatake, Noriko Ouji-Sageshima, Satoshi Ueha, Misaki Koyama, Tsukasa Uranaka, Kenji Kondo, Tatsuya Yamasoba · 2022 · Frontiers in Cellular and Infection Microbiology
  24. Diabetic ketoacidosis incidence among children with new‐onset type 1 diabetes in Poland and its association with COVID ‐19 outbreak—Two‐year cross‐sectional national observation by PolPeDiab Study Group
    Iwona Pietrzak, Arkadiusz Michalak, Sebastian Seget, Maria Bednarska, Iwona Beń‐Skowronek, Artur Tadeusz Bossowski, Agata P Chobot, Katarzyna Dżygało, Barbara Głowińska‐Olszewska, Martyna Górnicka et al. · 2022 · Pediatric Diabetes
  25. Coronaviral Infection and Interferon Response: The Virus-Host Arms Race and COVID-19
    Qi Liu, Sensen Chi, Kostyantyn V. Dmytruk, Olena V. Dmytruk, Shuai Tan · 2022 · Viruses
  26. Promising natural products against SARS‐CoV ‐2: Structure, function, and clinical trials
    Yan Zhao, Shanshan Deng, Yujiao Bai, Jinlin Guo, Guoyin Kai, Xinhe Huang, Xu Jia · 2022 · Phytotherapy Research
  27. LRRC15 inhibits SARS-CoV-2 cellular entry in trans
    Jaewon Song, Ryan Dz-Wei Chow, Mario A. Peña-Hernández, Li Zhang, Skylar A. Loeb, Eui Young So, Olin D. Liang, Ping Ren, Sidi Chen, Craig B. Wilen et al. · 2022 · PLoS Biology
  28. Vascular dysfunction in COVID-19 patients: update on SARS-CoV-2 infection of endothelial cells and the role of long non-coding RNAs
    Jaroslav Pelisek, Benedikt Reutersberg, Urs F. Greber, Alexander Zimmermann · 2022 · Clinical Science
  29. Angiopoietin-Like4 Is a Novel Marker of COVID-19 Severity
    Pavan K. Bhatraju, Eric D. Morrell, Ian B. Stanaway, Neha Alhad Sathe, Avantika Srivastava, Radu Postelnicu, Richard R. Green, Adair Andrews, Martin Gonzalez, Christopher J. Kratochvil et al. · 2022 · Critical Care Explorations
  30. Nanotechnology and COVID-19: Prevention, diagnosis, vaccine, and treatment strategies
    Sümeyra Ayan, Kubra Aranci, Fatih Çiftçi, Cem Bülent Üstündağ · 2023 · Frontiers in Materials
  31. Receptors and Cofactors That Contribute to SARS-CoV-2 Entry: Can Skin Be an Alternative Route of Entry?
    M. Barthe, Leslie Hertereau, Noura Lamghari, H. Osman-Ponchet, V. Braud · 2023 · International Journal of Molecular Sciences
  32. The Role of the Nuclear Factor-Kappa B (NF-κB) Pathway in SARS-CoV-2 Infection
    Periyanaina Kesika, Subramanian Thangaleela, Natarajan Sisubalan, Arumugam Radha, Bhagavathi Sundaram Sivamaruthi, Chaiyavat Chaiyasut · 2024 · Pathogens
  33. The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play
    Pedro Filho Noronha Souza, Felipe Pantoja Mesquita, Jackson L. Amaral, Patrícia G.C. Landim, Karollyny Roger Pereira Lima, Marília Braga Costa, Izabelle Rocha Farias, Luína Benevides Lima, Raquel Carvalho Montenegro · 2021 · International Journal of Biological Macromolecules
  34. Analyzing master regulators and scRNA-seq of COVID-19 patients reveals an underlying anti-SARS-CoV-2 mechanism of ZNF proteins
    Shijie Qin, Weijun Xu, Canbiao Wang, Sizhu Jiang, Wei Dai, Yang Yang, Jiawei Shen, Ping Jin, Fei Ma, Xinyi Xia · 2021 · Briefings in Bioinformatics
  35. Expression map of entry receptors and infectivity factors for pan-coronaviruses in preimplantation and implantation stage human embryos
    Stacy Colaco, Karisma Chhabria, Domdatt Singh, Anshul Bhide, Neha Singh, Amit Kumar Singh, Atahar Husein, Anuradha Mishra, Radhey Shyam Sharma, Nancy Ashary et al. · 2021 · Journal of Assisted Reproduction and Genetics
  36. Current status of the COVID‐19 and male reproduction: A review of the literature
    Edson Borges, Amanda Souza Setti, Assumpto Iaconelli, D. P. A. F. Braga · 2021 · Andrology
  37. Correlations between Kidney and Heart Function Bioindicators and the Expressions of Toll-Like, ACE2, and NRP-1 Receptors in COVID-19
    Rabab Hussain Sultan, Maged Abdallah, Tarek Mohamed Ali, Hebatallah Hany Assal, Amr E. Ahmed, Basem Hassan Elesawy, Osama M. Ahmed · 2022 · Vaccines
  38. An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection
    Devaux, Christian A., Camoin-Jau, Laurence · 2022 · Frontiers in Microbiology
  39. Proteomics in the COVID‐19 Battlefield: First Semester Check‐Up
    Lucia Grenga, Jean Armengaud · 2020 · PROTEOMICS
  40. COVID-19 Pandemic: What about the Safety of Anti-Coronavirus Nanoparticles?
    Dina A. Mosselhy, Jenni Virtanen, Ravi Kant, Wei Dong He, Mady Elbahri, Tarja A. Sironen · 2021 · Nanomaterials
  41. Reducing SARS-CoV-2 pathological protein activity with small molecules
    Donata Pluskota‐Karwatka, Marcin Hoffmann, Jan Barciszewski · 2021 · Journal of Pharmaceutical Analysis
  42. Viral Interactions with Adaptor-Protein Complexes: A Ubiquitous Trait among Viral Species
    Ivana Strazic Geljic, Paola Kučan Brlić, Lucija Musak, Dubravka Karner, Andreja Ambriović‐Ristov, Stipan Jonjić, Peter V. Schu, Tihana Lenac Roviš · 2021 · International Journal of Molecular Sciences
  43. Age-dependent appearance of SARS-CoV-2 entry sites in mouse chemosensory systems reflects COVID-19 anosmia-ageusia symptoms
    Julien Brechbühl, Ana Catarina Lopes, Dean Wood, Sofiane Bouteiller, Aurélie de Vallière, Chantal Verdumo, Marie-Christine Broillet · 2021 · Communications Biology
  44. The Antiviral Roles of Hydrogen Sulfide by Blocking the Interaction between SARS‐CoV‐2 and Its Potential Cell Surface Receptors
    Jing Dai, Xu Teng, Sheng Jin, Yuming Wu · 2021 · Oxidative Medicine and Cellular Longevity
  45. People critically ill with COVID-19 exhibit peripheral immune profiles predictive of mortality and reflective of SARS-CoV-2 lung viral burden
    Anthony Richard Cillo, Ashwin Somasundaram, Feng Shan, Carly Cardello, Creg J. Workman, Georgios D. Kitsios, Ayana T. Ruffin, Sheryl R. Kunning, Caleb Lampenfeld, Sayali Onkar et al. · 2021 · Cell Reports Medicine
  46. Interactions of Renin-Angiotensin System and COVID-19: The Importance of Daily Rhythms in ACE2, ADAM17 and TMPRSS2 Expression
    Jana Zlacká, Katarína Stebelová, Michal Zeman, Iveta Herichová · 2021 · Physiological Research
  47. Neuroinflammation in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection: Pathogenesis and clinical manifestations
    Graciela Cárdenas, Gladis Fragoso, Edda Sciutto · 2021 · Current Opinion in Pharmacology
  48. SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants
    Archana Panikkar, Katie E. Lineburg, Jyothy Raju, Keng Yih Chew, George R. Ambalathingal, Sweera Rehan, Srividhya Swaminathan, Pauline Crooks, Laëtitia Le Texier, Leone Beagley et al. · 2022 · PLoS Pathogens
  49. The role of circadian clock pathways in viral replication
    Xiaodong Alan Zhuang, Rachel S. Edgar, Jane A. McKeating · 2022 · Seminars in Immunopathology
  50. Clinical and Molecular Relationships between COVID-19 and Feline Infectious Peritonitis (FIP)
    Arjun Sweet, Nicole M. André, Alison E. Stout, Beth Nicole Licitra, Gary R. Whittaker · 2022 · Viruses
  51. The Path to Therapeutic Furin Inhibitors: From Yeast Pheromones to SARS-CoV-2
    Gary Thomas, Frédéric Couture, Anna Kwiatkowska · 2022 · International Journal of Molecular Sciences
  52. Comprehensive role of SARS‐CoV‐2 spike glycoprotein in regulating host signaling pathway
    Shuvomoy Banerjee, Xinyu Wang, Shujuan Du, Caixia Zhu, Yuping Jia, Yuyan Wang, Qiliang Cai · 2022 · Journal of Medical Virology
  53. Tangled quest of post-COVID-19 infection-caused neuropathology and what 3P nano-bio-medicine can solve?
    Nadia Μ. Hamdy, Fatma H. Shaker, Xianquan Zhan, Emad B. Basalious · 2022 · The EPMA Journal
  54. The impact of infection with COVID-19 on the respiratory microbiome: A narrative review
    Taiping Zhu, Jun Jang Jin, Minhua Chen, Yingjun Chen · 2022 · Virulence
  55. SARS-CoV-2 induced hepatic injuries and liver complications
    Umar Saeed, Zahra Zahid Piracha, Sara Rizwan Uppal, Yasir Waheed, Rizwan Uppal · 2022 · Frontiers in Cellular and Infection Microbiology
  56. Upregulation of PD‐L1 by SARS‐CoV‐2 promotes immune evasion
    Hsiang‐Chi Huang, Shih‐Han Wang, Guo‐Chen Fang, Wen‐Cheng Chou, Chun‐Che Liao, Cheng‐Pu Sun, Jia‐Tsrong Jan, Hsiu‐Hua Ma, Hui‐Ying Ko, Yi‐An Ko et al. · 2023 · Journal of Medical Virology
  57. Elevated CD39+T-Regulatory Cells and Reduced Levels of Adenosine Indicate a Role for Tolerogenic Signals in the Progression from Moderate to Severe COVID-19
    Alaa Elsaghir, Ehsan M. W. El-Sabaa, Asmaa Mohamed Zahran, Sahar A. Mandour, Eman Hassan Ali Salama, Sahar Aboulfotuh, Reham Mohammed El-morshedy, Stefania Tocci, Ahmed Mandour, Wael Esmat Ali et al. · 2023 · International Journal of Molecular Sciences
  58. Neuroinvasion and neurotropism of severe acute respiratory syndrome coronavirus 2 infection
    Michelle Jagst, Lilli Pottkämper, André Gömer, Kalliopi Pitarokoili, Eike Steinmann · 2024 · Current Opinion in Microbiology
  59. Osmotic Adaptation by Na+-Dependent Transporters and ACE2: Correlation with Hemostatic Crisis in COVID-19
    Danah Muhanna, Shanvanth R. Arnipalli, Shashi Bhushan Kumar, Ouliana Ziouzenkova · 2020 · Biomedicines
  60. SARS-CoV-2—Morphology, Transmission and Diagnosis during Pandemic, Review with Element of Meta-Analysis
    Katarzyna Grudlewska‐Buda, Natalia Wiktorczyk-Kapischke, Ewa Wałecka-Zacharska, Joanna Kwiecińska-Piróg, Katarzyna Buszko, Kamil Leis, Klaudia Juszczuk, Eugenia Gospodarek-Komkowska, Krzysztof Skowron · 2021 · Journal of Clinical Medicine
  61. TRPV2-spike protein interaction mediates the entry of SARS-CoV-2 into macrophages in febrile conditions
    Jinrui Xu, Yuquan Yang, Zhaoyuan Hou, Hao Jia, Yujiong Wang · 2021 · Theranostics
  62. SARS-CoV-2 S1 Protein Induces Endolysosome Dysfunction and Neuritic Dystrophy
    Gaurav Datta, Nicole Miller, Peter W. Halcrow, Nabab Khan, Timothy Colwell, Jonathan D. Geiger, Xuesong Chen · 2021 · Frontiers in Cellular Neuroscience
  63. K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research
    Simona Dedoni, Valeria Avdoshina, Chiara Camoglio, Carlotta Siddi, Walter Fratta, María Scherma, Paola Fadda · 2022 · Molecules
  64. SARS-CoV-2 infects human adipose tissue and elicits an inflammatory response consistent with severe COVID-19
    Giovanny J. Martínez-Colón, Kalani Ratnasiri, Richard Chen, Sizun Jiang, ELIZABETH J. ZANLEY, Arjun Rustagi, Renu Verma, Han M. Chen, Jason Randolph Andrews, Kirsten D. Mertz et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  65. Counter-regulatory renin-angiotensin system in hypertension: review and update in the era of COVID-19 pandemic
    Chen, Hongyin, Peng, Jiangyun, Wang, Tengyao, Wen, Jielu, Chen, Sifan, Huang, Yu, Zhang, Yang · 2023 · Biochemical Pharmacology
  66. The use of human iPSC‐derived alveolar organoids to explore SARS‐CoV‐2 variant infections and host responses
    Chaitanya Gandikota, Kishore Vaddadi, Pulavendran Sivasami, Chaoqun Huang, Yurong Liang, Samuel Pushparaj, Xufang Deng, Rudragouda Channappanavar, Jordan Patrick Metcalf, Lin Liu · 2024 · Journal of Medical Virology
  67. Alveolar Macrophages in Viral Respiratory Infections: Sentinels and Saboteurs of Lung Defense
    Pauline Pöpperl, Melanie Stoff, Andreas Beineke · 2025 · International Journal of Molecular Sciences
  68. On the Origin of SARS-CoV-2: Did Cell Culture Experiments Lead to Increased Virulence of the Progenitor Virus for Humans?
    Bernd Kaina · 2021 · In Vivo
  69. Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein
    Hristo L. Svilenov, Julia Sacherl, A. Reiter, Lisa S. Wolff, Cho‐Chin Cheng, Marcel Stern, Vincent Grass, Martin Feuerherd, Frank‐Peter Wachs, Nicole Simonavicius et al. · 2021 · Antiviral Research
  70. A mouse model of lethal respiratory dysfunction for SARS-CoV-2 infection
    Esther Shuyi Gan, Ayesa Syenina, Martin Linster, Benson Ng, Summer Li-Xin Zhang, Satoru Watanabe, Ravisankar Rajarethinam, Hwee Cheng Tan, Gavin J. D. Smith, Eng Eong Ooi · 2021 · Antiviral Research
  71. Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19?
    Christian Albert Devaux, Cléa Melenotte, Marie‐Dominique Piercecchi‐Marti, Clémence Delteil, Didier Raoult · 2021 · Frontiers in Medicine
  72. An Update on Innate Immune Responses during SARS-CoV-2 Infection
    Yu Long Zhang, Shuaiyin Chen, Yuefei Jin, Wangquan Ji, Weiguo Zhang, Guangcai Duan · 2021 · Viruses
  73. Cardiac Fibrosis Is a Risk Factor for Severe COVID-19
    Julian Mustroph, Julian Hupf, Maria J. Baier, Katja Evert, Christoph Brochhausen, Katharina A.E. Broeker, Christine Meindl, Benedikt Seither, Carsten Gerald Jungbauer, Matthias Evert et al. · 2021 · Frontiers in Immunology
  74. m6A Regulator-Mediated Methylation Modification Patterns and Characteristics of Immunity in Blood Leukocytes of COVID-19 Patients
    Xiangmin Qiu, Xiaoliang Hua, Qianyin Li, Qin Zhou, Juan Chen · 2021 · Frontiers in Immunology
  75. The spike-ACE2 binding assay: An in vitro platform for evaluating vaccination efficacy and for screening SARS-CoV-2 inhibitors and neutralizing antibodies
    Shuangzhe Zhang, Chunhui Gao, Tuhin Das, Shuhong Luo, Hao Tang, Xinyi Yao, Chih Yun Cho, Jingqiao Lv, Kino Maravillas, Valerie Sloane Jones et al. · 2022 · Journal of Immunological Methods
  76. New‐onset type 1 diabetes and severe acute respiratory syndrome coronavirus 2 infection
    Roy Anindya, Guy A. Rutter, Gargi Meur · 2022 · Immunology and Cell Biology
  77. Analysis of the N-glycosylation profiles of the spike proteins from the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2
    Dongxia Wang, Jakub Baudys, Sarah H. Osman, John Robert Barr · 2023 · Analytical and Bioanalytical Chemistry
  78. Mechanism and treatment of olfactory dysfunction caused by coronavirus disease 2019
    Bian Hu, Mengdan Gong, Yizhen Xiang, Siyuan Qu, Hai Hong Zhu, Dong Ye · 2023 · Journal of Translational Medicine
  79. Sequential glycosylations at the multibasic cleavage site of SARS-CoV-2 spike protein regulate viral activity
    Shengjun Wang, Wei Ran, Lingyu Sun, Qingchi Fan, Yuanqi Zhao, Bowen Wang, Jinghong Yang, Yuqi He, Ying Ta Wu, Yuanyuan Wang et al. · 2024 · Nature Communications
  80. Dysbalance of ACE2 levels – a possible cause for severe COVID ‐19 outcome in COPD
    Elisabeth Fließer, Anna Birnhuber, Leigh Matthew Marsh, Elisabeth Gschwandtner, Walter Klepetko, Horst Olschewski, Grażyna Kwapiszewska · 2021 · The Journal of Pathology Clinical Research
  81. Natural variants in SARS-CoV-2 Spike protein pinpoint structural and functional hotspots with implications for prophylaxis and therapeutic strategies
    Suman Pokhrel, Benjamin R. Kraemer, Scott Burkholz, Daria Mochly‐Rosen · 2021 · Scientific Reports
  82. COVID-19 and the Pediatric Nervous System: Global Collaboration to Meet a Global Need
    Michelle Elena Schober, Courtney Robertson, Mark S. Wainwright, Juan D. Roa, Ericka L. Fink · 2021 · Neurocritical Care
  83. Interfering effects on the bioactivities of several key proteins of COVID-19/variants in diabetes by compounds from Lianqiao leaves: In silico and in vitro analyses
    Yishan Fu, Fei Pan, Lei Zhao, Shuai Zhao, Junjie Yi, Shengbao Cai · 2022 · International Journal of Biological Macromolecules
  84. The effect of coronaviruses on olfaction: systematic review
    Mislav Zugaj, N.S. van Ditzhuijzen, Korneliusz Golebski, Wytske Johanna Fokkens · 2021 · Rhinology Journal
  85. An Overview of Current Knowledge of Deadly CoVs and Their Interface with Innate Immunity
    Yamei Zhang, Siobhán Gargan, Yongxu Lu, Nigel J. Stevenson · 2021 · Viruses
  86. Original Hosts, Clinical Features, Transmission Routes, and Vaccine Development for Coronavirus Disease (COVID-19)
    Ting Wu, Shuntong Kang, Wenyao Peng, Chenzhe Zuo, Yuhao Zhu, Liangyu Pan, Keyun Fu, Yaxian You, Xinyuan Yang, Xuan Luo et al. · 2021 · Frontiers in Medicine
  87. Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?
    Mariele Montanari, Barbara Canonico, Evelyn Nordi, Daniela Vandini, Simone Barocci, Serena Benedetti, Eugenio Carlotti, Loris Zamai · 2021 · Advances in Biological Regulation
  88. Perspectives and potential approaches for targeting neuropilin 1 in SARS-CoV-2 infection
    S. Chapoval, A. Keegan · 2021 · Molecular Medicine
  89. Computational screening of potential drugs against COVID-19 disease: the Neuropilin-1 receptor as molecular target
    Hicham Charoute, Zouhair Elkarhat, Lamiae Elkhattabi, Elmostafa El Fahime, Naoual Oukkache, Hassan Rouba, Abdelhamid Barakat · 2022 · VirusDisease
  90. Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling
    Elena I. Frolova, Oksana Palchevska, Tetyana Lukash, Francisco de Borja Pérez Domínguez, William J. Britt, Ilya V. Frolov · 2022 · Journal of Virology
  91. COVID-19 and Alzheimer's Disease: Neuroinflammation, Oxidative Stress, Ferroptosis, and Mechanisms Involved
    Alicia Beatriz Pomilio, Arturo Alberto Vitale, Alberto Lazarowski · 2022 · Current Medicinal Chemistry
  92. Single-nucleus transcriptomic profiling of multiple organs in a rhesus macaque model of SARS-CoV-2 infection
    Qiang Ma, 中国科学院生物物理研究所脑与认知科学国家重点实验室, 北京100101, 中国, Wenji Ma, Tian‐Zhang Song, Zhaobo Wu, Zeyuan Liu, Zhenxiang Hu, Jian-Bao Han, Ling Xu, Bo Zeng et al. · 2022 · 动物学研究
  93. AI-CoV Study: Autoimmune Encephalitis Associated With COVID-19 and Its Vaccines—A Systematic Review
    M. M. Samim, Debjyoti Dhar, Sheetal Goyal, Treshita Dey, Naznin Parvin, Rutul Shah, Vikram Singh, Sampurna Chowdhury, Bhavesh Mohan Lal, Nibu Varghese et al. · 2022 · Journal of Clinical Neurology
  94. Blood-brain barrier function in response to SARS-CoV-2 and its spike protein
    Łukasz Suprewicz, Krzysztof Fiedoruk, Agata Czarnowska, Marcin Sadowski, Agnieszka Strzelecka, Peter A. Galie, Paul A. Janmey, Alina Kułakowska, Robert Bucki · 2023 · Neurologia i Neurochirurgia Polska
  95. SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness?
    Alessandra Sacchi, Flavia Giannessi, Andrea Sabatini, Zulema Antonia Percario, Elisabetta Affabris · 2023 · International Journal of Molecular Sciences
  96. Is neuropilin-1 the neuroimmune initiator of multi-system hyperinflammation in COVID-19?
    Kiarash Saleki, Parsa Alijanizadeh, Abbas Azadmehr · 2023 · Biomedicine & Pharmacotherapy
  97. High‐resolution single‐cell transcriptomic survey of cardiomyocytes from patients with hypertrophic cardiomyopathy
    Jiansen Lu, Jie Ren, Jie Liu, Minjie Lu, Yueli Cui, Yuhan Liao, Yuan Zhou, Yun Gao, Fuchou Tang, Jizheng Wang et al. · 2023 · Cell Proliferation
  98. Integration of human organoids single‐cell transcriptomic profiles and human genetics repurposes critical cell type‐specific drug targets for severe COVID ‐19
    Yunlong Ma, Yijun Zhou, Dingping Jiang, Wei Dai, Jinɡjinɡ Li, Chunyu Deng, Chen Cheng, Gongwei Zheng, Yaru Zhang, Fei Qiu et al. · 2023 · Cell Proliferation
  99. Integrin αvβ1 facilitates ACE2-mediated entry of SARS-CoV-2
    Zeqiong Cai, Han Bai, Doudou Ren, Biyun Xue, Yijia Liu, Tian Gong, Xuan Zhang, Peng Zhang, Junsheng Zhu, Binyin Shi et al. · 2023 · Virus Research
  100. COVID-19 and Alzheimer’s Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future
    Giuseppina Amadoro, Valentina Latina, Egidio Stigliano, Alessandra Micera · 2023 · Cells